Some stock data isn't available right now.
Summit Therapeutics Inc. Common Stock (SMMT)
Underlying price
$15.61-1.33% today
Stock stats
- Market cap
- $12.6B
- Previous close
- $15.55
- Open
- $15.29
- Day's range
- $15.13 – $15.70
- 52-week range
- $12.07 – $29.23
- Volume
- 4.15M
- Avg volume
- 6.79M
- P/E ratio
- -
- EPS
- -$1.07
- Dividend yield
- -
- Beta
- -1.60
- Next earnings
- -
About Summit Therapeutics Inc. Common Stock
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
- Ticker
- SMMT
- Asset class
- Equity
- Tokenized by
- 0 issuers
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Employees
- 265
- Website
- smmttx.com